A retrospective evaluation of adverse drug reactions of azathioprine in patients with autoimmunological skin diseases
Journal Title: Postępy Dermatologii i Alergologii - Year 2006, Vol 23, Issue 3
Abstract
Azathioprine (AZA) – immunosuppressive prodrug is characterized by a high interindividual variability in bioavailability and metabolism. It is used in a broad spectrum of dermatological dysimmune diseases, either as the primary drug or as adjunctive treatment. AZA undergoes non-enzymatic conversion in the liver yielding 6-mercaptopurine which afterwards is converted into cytotoxic 6-thioguanine nucleoside. It exerts immunosuppressive activity by inhibiting DNA replication during immune response. Moreover, it may also decrease proliferation of bone marrow cells which may lead to myelosuppression. Thus, the therapeutic role of AZA is often discussed because of toxicity. The study aims to characterize the toxicity profile of AZA. This study is based on retrospective examination of data taken from the hospital notes of these patients who had been treated with AZA due to dermatological dysimmune diseases. Of 294 patients evaluated, 151 were treated with AZA at a dose 50-200 mg/day. Adverse reactions (ARs) were reported in 12,6% of patients. Most of ARs occurred in patients aged between 20 and 29 years and during the first six months of treatment. Hematological toxicity occurred in 7 patients and deranged liver enzymes in 5 during the treatment with AZA. Gastrointestinal disturbances were reported by 6 patients. The pancreatitis was recognized in one patient. We conclude that azathioprine-induced toxicity should be diagnosed early and routine monitoring for its toxicity should include full blood count and liver function tests.
Authors and Affiliations
Maciej Jankowski, Elżbieta Grubska-Suchanek, Małgorzata Ruszczyńska, Jadwiga Roszkiewicz, Mirosława Szczepańska-Konkel
Keywords
Related Articles
- EP ID EP112808
- DOI -
- Views 53
- Downloads 0
Klippel-Trenaunay Syndrome coexisting with others vascular abnormalities
Klippel-Trenaunay syndrome (KTS) is a rare congenital malformation characterized by the triad of macular vascular naevus, soft tissue and/or skeletal hypertrophy and venous varicosities. Despite of mentioned features KTS...
Stem cell factor levels (SCF) in plasma and fibroblast cultures of scleroderma or systematic mastocytosis patients
Stem cell factor (SCF) is a pleiotropic cytokine, in the skin released mainly by fibroblasts and endothelial cells. It was demonstrated that SCF exerts stimulatory effect on human mast cells, which are in turn postulated...
Placebo effect in treatment of pain associated with venous leg ulcers
Venous leg ulcers constitute a major therapeutic and social problem. This chronic recurrent condition concerns mostly elderly patients, often suffering from a number of other diseases, thus adding to their disability. Lo...
Sprawozdanie z Food Allergy Training Course 8–11 kwietnia 2006 r., Hindsgavl Castle, Middlefart, Dania
Nowe spojrzenie na problem alergii na lateks; grupy ryzyka, objawy, rozpoznawanie, zapobieganie
W pracy przedstawiono najnowsze doniesienia, dotyczące występowania alergii na lateks w krajach wysoko rozwiniętych i w Polsce. Z przeglądu piśmiennictwa wynika, że częstość rozpoznawania alergii na lateks w krajach Euro...